The Center for Scientific Review (CSR) is the portal for United StatesNational Institutes of Health (NIH) grant applications and their review for scientific merit. The CSR organizes the peer review groups or study sections that evaluate the majority (76%) of the research grant applications sent to NIH. It also receives all grant applications for NIH, as well as for some other components of the United States Department of Health and Human Services (DHHS). Since 1946, its mission has remained clear and timely: to see that NIH grant applications receive fair, independent, expert, and timely reviews—free from inappropriate influences—so NIH can fund the most promising research.
CSR receives nearly 80,000 applications a year and recruits over 19,000 external experts to review its portion of them in its study sections, which often meet three times during the year. Additional scientists serve on other NIH advisory councils, which provide a second level of peer review and make funding recommendations based on priorities set by the United States Congress, DHHS, and the public.
From 1946 to 1997, the CSR was known as the Division of Research Grants (DRG).
Directors
Past directors from 1946 - present
No.
Portrait
Director
Took office
Left office
Refs.
1
Cassius James Van Slyke
January 1946
December 1, 1959
2
David E. Price MD
1948
1950
3
Ernest M. Allen
1951
1960
4
Dale R. Lindsay
1960
1963
5
Eugene A. Confrey
October 1963
1969
6
Stephen P. Hatchett
May 1969
August 22, 1976
acting
Carl D. Douglass
August 1976
April 1977
7
April 1977
May 3, 1985
8
Jerome G. Green
January 1986
June 1, 1995
9
Ellie Ehrenfeld
January 1, 1997
September 30, 2003
acting
Brent Stanfield
October 1, 2003
June 30, 2005
10
Antonio Scarpa
July 1, 2005
September 2, 2011
acting
Richard K. Nakamura
September 18, 2011
December 3, 2012
11
December 3, 2012
April 30, 2018
12
Noni Byrnes
February 14, 2019
Present
Current initiatives
Shorten the review process so applicants can revise and resubmit their applications in the next review round if necessary and NIH can more timely fund the best research. Shortening the review process by 45 days could thus reduce the time to resubmit by four months.
Recruit and retain the best reviewers so NIH and applicants receive the best advice.
Foster a culture more favorable to innovative applications, so that NIH can fund research that promises larger advances in science and health.
Address the concern that clinical research is not properly evaluated, so this important research is well represented in the NIH program.
Increase the transparency, accountability, and uniformity of NIH peer review.